UNICHEM LABORATORIES LTD. - 506690 - Related Party Transactions For Half Year Ended 30.9.2022
Related Party transactions for half year ended 30.9.202224-11-2022
24-11-2022
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Duplicate Share Certificate has been issued based on receipt of requisite documentation received from the Shareholder.23-11-2022
UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Financial Results for the second quarter and six months ended September 30, 2022 published in the newspapers on November 12, 2022 .12-11-2022
UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Outcome for Financial Results For The Quarter And Six Months Ended September 30, 2022
Financial Results for the quarter and six months ended September 30, 202211-11-2022
UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for Approving The Financial Results For The Quarter And Six Months Ended September 30, 2022
UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Board meeting on 11.11.2022 for inter-alia approving the financial results for the quarter and six months ended September 30, 202203-11-2022
Stock of this pharma company has zoomed nearly 90% in last four months
In the past three months, Unichem Labs has received abbreviated new drug application (ANDA) approvals for four drugs from the United States Food and Drug Administration (USFDA)03-11-2022
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate / Duplicate Certificate21-10-2022
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation about the loss/misplacement of Share Certificate(s), as received from Link Intime India Pvt Ltd, the Registrar & Share Transfer Agents of Company.19-10-2022
UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under regulation 74[5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022.18-10-2022
UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release pertaining to receipt of ANDA approval from United States Food and Drug Administration (USFDA) for Unichem's Extended Phenytoin Sodium Capsules USP, 100 mg.14-10-2022